Nadroparin - CISMeF

Preferred Label : Nadroparin;

NCIt definition : A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by depolymerization of porcine mucosal sodium heparin, extraction and purification. Upon administration, nadroparin binds to antithrombin III (ATIII) and inhibits the activity of activated factor X (factor Xa), thereby inhibiting the final common pathway of the coagulation cascade and preventing the formation of a cross-linked fibrin clot.;

UNII : 1K5KDI46KZ;

CAS number : 9005-49-6;

NCI Metathesaurus CUI : CL1915375;

Codes from synonyms : 346;

Details

Origin ID

C200713;

UMLS CUI

C0206232;

Currated CISMeF NLP mapping
- Nadroparin [SMS substance]
- Nadroparin [ICD-11 Extension code]
- Nadroparin (substance) [SNOMED CT concept]
- nadroparin [MeSH concept]
- nadroparin [MeSH Descriptor]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Nadroparin (substance) [SNOMED CT concept]
- Product containing nadroparin (medicinal product) [SNOMED CT concept]
- nadroparin [MeSH Descriptor]
- nadroparin [MeSH concept]
- nadroparin [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
has_salt_form
- Nadroparin Calcium [NCIt concept]
is_free_acid_or_base_form_of
- Nadroparin Calcium [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients